Case Report
Copyright ©The Author(s) 2021.
World J Clin Cases. Aug 6, 2021; 9(22): 6566-6574
Published online Aug 6, 2021. doi: 10.12998/wjcc.v9.i22.6566
Figure 3
Figure 3 Immunohistochemical features. The tumor cells were positive for B-lymphocyte marker CD20/CD79a and negative for T-lymphocyte marker CD3. 10%-20% of the cells were positive for Ki-67. A: CD20; B: CD79a; C: CD3; D: Ki-67.